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Zoonoses as causes of human infections have been increasingly reported, and many of these are viruses that cause central nervous
systeminfections.Thispaperfocusesonthehenipaviruses(familyParamyxoviridae,genushenipavirus)thathaverecentlyemerged
to cause severe encephalitis and systemic infection in humans and animals in the Asia-Paciﬁc region. The pathological features
inthehumaninfectionscomprisevasculopathy(vasculitis,endothelialmultinucleatedsyncytia,thrombosis,etc.)andparenchymal
cell infection in the central nervous system, lung, kidney, and other major organs. Most animals naturally or experimentally
infected show more or less similar features conﬁrming the dual pathogenetic mechanism of vasculopathy-associated microinfarc-
tion and direct extravascular parenchymal cell infection as causes of tissue injury. The most promising animal models include the
hamster,ferret,squirrelmonkey,andAfricangreenmonkey.Withincreasingevidenceofinfectioninthenaturalhosts,thepteropid
bats and, hence, probable future outbreaks in many more countries, a greater awareness of henipavirus infection in both humans
and animals is imperative.
1.ZoonoticVirusesAssociatedwith
Viral Encephalitis
Numerous emerging infections are zoonoses of known or
newlydiscoveredvirusesthathavejumpedthespeciesbarrier
to infect humans. These include the human immunodeﬁ-
ciency virus (HIV), arboviruses, lyssavirus, henipaviruses,
avian, and swine inﬂuenza viruses [1–8]. Many of these
zoonotic viruses cause severe encephalitis associated with
signiﬁcant mortality and morbidity.
Since its origin has been traced to African nonhuman
primates, HIV has become established in human popula-
tions [1]. The prevalence of HIV encephalitis is unknown;
perhaps hundreds of thousands suﬀer from this condition
since millions of HIV-infected patients still do not have
adequate antiretroviral therapy. Among the arboviruses,
Japanese encephalitis virus (JEV) infections, transmitted by
mosquitoes from birds, is probably the most important, with
more than 50,000 patients from the Indian subcontinent
and southeast Asia [5]. West Nile virus, another known,
similarly transmitted arbovirus, recently emerged to cause
human neuroinvasive disease in North America, a region not
previously known to be aﬀected [9, 10].
Henipavirus genus, a recently established group of par-
amyxoviruses [11] comprising the Hendra virus (HEV) and
Nipah virus (NIV), has emerged to cause severe encephalitis
in humans and animals. There are several previous reviews
on NiV or henipavirus infections [12–17], but the present
one focuses on the epidemiology, clinical features, and com-
parative pathology in infected humans and animals and also
includes some previously unpublished data.
HeV was ﬁrst isolated after an outbreak in horses and 2
humansinthetownofHendra,QLD,Australiain1994.Since
then several other small outbreaks involving horses only, or
horses and their carers, have been reported only in Australia
and mainly in Queensland. Scores of horses and 7 humans
(4 fatalities) have been infected so far [17–24]. NiV was
named after the Nipah River village in Malaysia, very soon
after the ﬁrst known outbreak occurred mainly around pig
farms from 1989 to 1999. Although a prevalence of 265
Malaysian cases of acute NiV encephalitis with 105 fatalities
has been reported [25], the subsequent spread of the virus2 Pathology Research International
to Singapore and its ability to cause mild infections [26]
suggested that the total number infected was probably more
than 350 cases [14]. After the outbreak was controlled in
Malaysia and Singapore in1999, at the beginning of 2001,
several recurrent NiV outbreaks were reported from Bang-
ladesh and the adjacent Bengal area of India [27, 28] that
have involved more than 120 people thus far.
2. HenipavirusTransmission
The natural host of henipaviruses is the fruit bat (Pteropus
species or “ﬂying foxes”) [29–31], and bat-to-human trans-
mission may be direct or indirect via intermediate hosts. The
horse is the main if not the only intermediate host for HeV
transmission [18, 23, 24]. Numerous other domestic animals
and wildlife investigated were negative for naturally acquired
HeV infection [21]. Contact with virus in horse oronasal
secretions and urine appears to be the most likely route
of transmission [32, 33]. Although person-to-person HeV
transmission has not been reported, involvement of the lung
and kidney in acute infection and presence of virus in
nasopharyngeal secretions strongly suggest this possibility.
The natural mode of bat-to-horse transmission remains
unclear and unproven experimentally [32]. It was suggested
thatingestionoffeedorpasturecontaminatedbybat-derived
foetal tissues or urine may be responsible.
IntheMalaysia/Singaporeoutbreak,thepigwasthemain
intermediate host and human transmission was strongly
linked to close contact with pigs or fresh pig products [25,
34–37]. Massive culling of sick pigs and banning of exports
stopped the epidemic [36, 38]. Similar to HeV, demonstra-
tionofvirusinoropharyngeal/respiratorysecretionssuggests
spread by either direct contact or aerosols [39, 40]. In con-
trast, absence of virus in pig urine could indicate that spread
via urine may be ineﬃcient. It was suggested that bat-to-pig
transmissioncouldhaveresultedfromingestionofhalf-eaten
contaminated fruits dropped by bats near farms [29].
Person-to-person transmission in the Malaysian hospital
setting is probably very low, but a nurse could have been
infected from patients’ tracheal secretions or urine [41–44].
There is no documentation of such transmission among and
between farm workers and their families, but this remained
a distinct possibility. In contrast, in the Bangladesh/India
outbreaks, there was a high incidence of person-to-person
transmission involving health care workers or other people
[28, 45, 46]. No animals have been positively identiﬁed as
intermediatehostsalthoughtherewereassociationswithsick
cows, pigs, and goats [45, 47] Bat-contaminated, date palm
sapdrunkrawasalocaldelicacyhasbeenimplicatedinsome
cases of bat-to human transmissions in Bangladesh [48].
3. ClinicalAspects of HenipavirusInfection
Theincubationperiodrangesfromafewdaysto2weeks[19,
23, 24, 49, 50]. Milder symptoms include fever, headache,
inﬂuenza-like illness, and drowsiness. Severe HeV infection,
may present either as a neurological or a pulmonary syn-
drome, but since there have been very few patients, the clin-
ical features were not well characterized. Neurological signs
include confusion, motor deﬁcits and seizures while the pul-
monary syndrome presents with an inﬂuenza-like illness,
hypoxaemia, and diﬀuse alveolar shadowing in chest X-Rays
[23, 24]
Severe NiV encephalitic syndrome presents mainly with
fever, headache, dizziness, vomiting, and reduced conscious-
ness [50]. Clinical signs such as areﬂexia, hypotonia, abnor-
malpupillaryanddoll’seyereﬂex,tachycardia,hypertension,
myoclonus, meningism, and convulsions were observed. A
pulmonary syndrome has been described in some patients
who present with cough, atypical pneumonia, and abnormal
chest X-Ray ﬁndings [49–51]. Brain MR scans in acute
henipavirus encephalitis show typical, disseminated, small
discrete hyperintense lesions in both grey and white matter
[23, 52, 53].
Speciﬁc antihenipavirus antibodies that can be detected
in the serum and cerebrospinal ﬂuid (CSF) in most patients
arecriticaltodiagnosis.Moreisknownaboutseroconversion
after NiV infection than HeV infection. In NiV infection,
IgM seroconversion by about 2 weeks was 100% and per-
sistedformorethan3months.IgGseroconversionwas100%
by about 3 weeks and may persist for several years [54,
55]. Speciﬁc neutralizing IgM or IgG antibodies have been
reported in HeV-infected patients [19, 20, 24].
CSF examination showed elevated protein levels and/or
white cell counts in more than 75% of NiV patients, but glu-
cose levels were normal [50, 56]. Electroencephalography
most commonly showed continuous, diﬀuse, symmetrical
slowing with or without focal discharges in acute NiV en-
cephalitis [57].
Mortality in HeV infection is about 50%, while in severe
NiV infection it ranges from about 40% (Malaysia) to 70%
(Bangladesh/India) [25, 27, 28]. In acute NiV encephalitis,
brainstem involvement, presence of virus in the CSF, and
diabetes mellitus are poor prognostic indicators [50, 58, 59].
The majority of Malaysian patients apparently recovered
with no serious sequelae. However, henipavirus infection
may be complicated by relapsing encephalitis after initial
recovery. One case of relapsing HeV encephalitis and more
than 20 cases of relapsing NiV encephalitis (probably <10%
of survivors) have been reported thus far [20, 26]. The single
caseofrelapsingHeVencephalitisoccurredabout13months
after exposure, while an average of 8 months elapsed before
relapsing NiV encephalitis occurred. Some cases of relapsing
NiV encephalitis only had fever and headache during the
acute phase and have also been called “late-onset” encephali-
tis. Clinical, radiological, and pathological ﬁndings suggest
that relapsing NiV encephalitis is distinct from acute NiV
encephalitisandthatrelapsinghenipavirusencephalitisisthe
result of viral recrudescence [13, 26, 52, 60].
4. Pathology of AcuteHenipavirusInfection
inHumans
Although published data on HeV infection consists of a
single case and most of the information on human heni-
pavirusinfectionisderivedfromNiVstudies,webelieveboth
viruses cause essentially the same pathology. Acute infectionPathology Research International 3
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Figure 1: Pathology of human and hamster henipavirus infection. (a) Vasculitis and associated intravascular thrombosis in human brain.
(b) In an uninﬂamed meningeal vessel, a multinucleated giant cell (arrow) with viral inclusion arises from the endothelial surface.
(c) Neuronal viral antigens in human Nipah infection. (d) Neuronal viral RNA in human Hendra infection. (e) Glomerulus in human
Nipah infection with thrombosis, necrosis, and peripheral multinucleated giant cell formation (arrowhead). (f) Mild vasculitis (arrows)
and encephalitis in Nipah-infected hamster brain. (g) Viral inclusions in neurons (arrowheads) and the rare neuronal syncytia (arrow) in
Nipah-infected hamster brain. (h) Nipah viral antigens in neurons and ependymal cells in infected hamster. (h and e) stains (a, b, e, f, g),
immunoperoxidase stains (c, h), in situ hybridisation (d). Magniﬁcation, objective ×20 (a, c, f, h), ×4 0( b ,d ,e ,g ) .
is characterized by disseminated small vessel vasculopa-
thy comprising true vasculitis, endothelial ulceration, and
intramural necrosis in the central nervous system (CNS),
lung, kidney, and many other major organs (Figure 1)[ 60,
61]. Occasionally, endothelial multinucleated giant cells or
syncytiamaybedetected(Figure 1(b)).Vascularocclusionby
vasculitis-inducedthrombosis(Figure 1(a))andperi vascular
haemorrhage were observed. Viral antigens, RNA, and nu-
cleocapsids could be detected in vascular endothelium,
multinucleated giant cells, and smooth muscle [61, 62].
In NiV infection, CNS vasculopathy was most severe
comparedtootherorgans.Vasculopathywasoftenassociated4 Pathology Research International
with discrete necrotic or more subtle vacuolar plaque-like
lesions that corresponded with lesions seen in the MR scans.
These lesions were characterized by necrosis, oedema, and
inﬂammation, and often viral antigens (Figure 1(c))a n d
RNA (Figure 1(d)) were demonstrable in adjacent neurons
[60].Hence,itisbelievedthatbothmicroinfarctionandneu-
ronal infection give rise to necrotic plaques. In some cases,
focal neuronophagia, microglial nodule formation, clusters
of foamy macrophages, perivascular cuﬃng, and meningitis
can be found. A more extensive review of the CNS pathology
has been published elsewhere [13]. In the lung, kidney
(Figure 1(e)), lymphoid organs, and so forth, vasculopathy,
parenchymal inﬂammation, and necrosis with occasional
multinucleated giant cells were also observed [60, 61].
5. Pathology of AcuteHenipavirusInfection
inAnimals
Consistent with in vitro experiments that showed extensive
infectivityofhenipavirusesindiﬀerentcelllines[63],natural
orinvivoexperimentalinfectionsonavarietyofmammalian
species have been reported. The table summarises these ﬁnd-
ings and is organized on the assumption that henipaviruses
as a group probably causes similar pathology in the same
animal species. We are aware there may yet be diﬀerences
between HeV and NiV infections in the same animal, but to
date there is no published study that directly compares these
viruses under identical experimental conditions.
Animals naturally infected by henipaviruses and whose
tissues have been examined for pathological changes are few
and include the dog, cat, horse, and pig [32, 40, 66, 84].
Hooper et al. described pulmonary inﬂammation and glom-
erular and tubular necrosis associated with syncytia forma-
tion in NiV-infected dogs [67]. We examined two naturally
infected dogs and found pulmonary vasculitis (Figure 2(a)),
alveolar oedema, and inﬂammation (unpublished data).
In the kidney, many glomeruli and adjacent tubules were
thrombosed or necrotic with varying degrees of inﬂamma-
tion (Figure 2(b)). Viral antigens and RNA were demon-
strated (Figure 2(c)). Serological studies conﬁrmed that the
dog is susceptible to NiV infection [71], but susceptibility to
HeV was inconclusive [21, 68]. Nonsuppurative meningitis,
cerebral ischaemia and vasculopathy have been described,
but there is no published data on direct neuronal infection
[67].
The cat is very susceptible to henipavirus infection under
natural or experimental conditions. Vasculopathy consisting
of vasculitis, endothelial syncytia, and viral immunolocal-
isation in endothelium and vascular smooth muscle was
observed in many organs, except perhaps in the brain pa-
renchyma, but meninges were involved (Table 1). There is
severe pulmonary inﬂammation, and bronchial epithelium
involvement may be prominent [40, 66, 67, 69]. Lymphoid
tissues, such as the spleen, lymph nodes, thymus, and Peyer’s
patches,andkidneyparenchymaltissuesincludingglomeruli
were often involved.
The horse as the intermediate host of HeV develops both
a pulmonary and an encephalitic syndrome [18, 33], the lat-
ter being recognized only more recently. As in other infected
animals, systemic vasculopathy is a prominent feature in the
lungs, CNS, kidney, and other organs (Table 1). Apart from
vasculopathy, observed encephalitis, necrosis and neuronal
changes in the CNS suggest direct neuronal infection, but
surprisingly so far there are no published reports to conﬁrm
this [67].
Naturally NiV-infected pigs develop a distinctive clinical
syndrome called “porcine respiratory and encephalitis syn-
drome” or “barking pig syndrome” [85]. As the latter name
suggests, pigs can develope a characteristic loud barking
cough, which diﬀers from other known porcine respiratory
diseases.Respiratorydistresswasalsoobservedinpigsexper-
imentally infected with henipaviruses [39, 81]. Neurological
signs included paralysis and abnormal movement and gait.
Many pigs however may remain asymptomatic or, having
developed clinical signs and symptoms, recover to a large
extent [85].
Instudiesofbothnaturalandexperimentalpiginfections
that we (unpublished data) and others have done, the
most severe pathology appears to be found in the respir-
atory system [39, 40, 81–83]. There was evidence of tra-
cheitis, bronchial inﬂammation, and pneumonia. Numerous
macrophages, neutrophils, and multinucleated cells can be
foundwithinalveoli(Figures2(d)and2(e))andbronchioles.
Epithelial syncytia arising from the bronchial epithelium
are prominent, and viral antigens and RNA (unpublished
data) could be demonstrated (Figures 2(f) and 2(h)). Vas-
culitis and multinucleated syncytial cells were seen in small
blood vessels (Figure 2(i)). Meningitis was characterised
by vasculitis, inﬂammation, and viral antigens localised to
the arachnoid membrane [40, 67]. Overall, encephalitis
was thought to be rare, but neuronal and peripheral
nerve infections have been demonstrated [39, 82]. Pe-
ripheral nerves may play a role in viral transmission into the
CNS, a phenomenon suggested so far only in the pig.
Several other animals that have been experimentally
infected successfully include the guinea pig, hamster, ferret,
nonhuman primates (squirrel monkey and African green
monkey), and chick embryo (Table 1). The infected guinea
pig shows extensive vasculopathy (Table 1) in the urinary
bladder, female reproductive tract, lymphoid organs, gas-
trointestinal tract, brain, and so forth. [64, 65, 74, 75, 84].
Notably, although pulmonary vasculopathy was described
[67], the lung generally showed mild inﬂammation. Viral
antigens and inclusions could be localised to neurons [74],
but higher viral doses may be needed to produce encephalitis
and/or neuronal infection [75]. Hamster tissues infected by
henipaviruses generally showed systemic vasculopathy and
parenchymal lesions in most major CNS and non-CNS
organs examined (Table 1)[ 76, 77]. In the CNS, there was
encephalitis, and there were viral inclusions, antigens and
RNA in the neurons (Figures 1(f) and 1(h)). Very rarely,
neuronal syncytia were observed (Figure 1(g)) (unpublished
data). In addition to vasculopathy, pneumonia, glomerulitis
and tubular lesions have been described. The squirrel
monkey and African green monkey are susceptible by heni-
paviruses, and results suggest that they are good nonhuman
primate animal models. As in the human infection, systemic
vasculopathy and involvement of a broad range of organsPathology Research International 5
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Figure 2: Pathology of dog and pig henipavirus infection. (a) Pulmonary vasculitis (arrow) and oedema in the Nipah-infected dog lung. (b)
Glomerular (arrow) and tubular necrosis in the dog kidney. (c) Nipah viral RNA in dog glomerulus (arrow). Intra-alveolar multinucleated
giantcellcontainingNipahviralinclusions(d)(arrow)andviralRNA(e)(arrow).Bronchiolarsyncytia(f)(arrow),viralantigens(g)(arrow)
and RNA (h) (arrow) in Nipah-infected pig lung. Endothelial giant cell in pig pulmonary vessel (i) (arrows). (h and e) stains (a, b, d, f),
immunoperoxidase stains (g, i), in situ hybridisation (c, e, h). Magniﬁcation, objective ×4( a ) ,×10 (b), ×20 (c), ×40 (d-i).
were detected (Table 1)[ 78–80]. More detailed analysis of
the pathological features in these models should enable
the pathogenesis of henipavirus infection to be further
investigated. Pathological data from the infected ferret shows
systemic vasculopathy and parenchymal lesions in the CNS
and non-CNS organs (Table 1)[ 72, 73]. The chick embryo
also shows evidence of extensive CNS and non-CNS involve-
ment suggesting that adult birds may also be susceptible to
henipaviruses, but so far there is no data available [70].
As the natural reservoir host of henipaviruses, it is not
surprising that experimentally infected bats did not develop
severe disease nor severe pathological changes (Table 1)Pathology Research International 9
[64, 65]. Interestingly, mouse and rat do not apparently
developclinicaldiseaseforreasonsyettobeinvestigated[76].
In general, the pathology described in various animal
species reﬂects the pathological features seen in the human
disease, namely, extensive vasculopathy, parenchymal lesions
in multiple organs, and evidence of viral infection. However,
there may be some signiﬁcant diﬀerences among animals.
In the pig and cat, respiratory tract involvement, notably of
the bronchial epithelium, stands out as a prominent feature.
In contrast, the guinea pig shows mild lung parenchymal
inﬂammation. Encephalitis and/or neuronal infection may
be more subtle in the pig and cat in contrast to human infec-
tion.
The pathological ﬁndings in the respiratory tracts of the
horse and pig, particularly the latter, are of course consistent
with the postulated modes of viral transmission to humans
via oropharyngeal/respiratory ﬂuids and aerosols. Interest-
ingly, negative virus isolation from pig urine suggests ineﬃ-
cient viral spread by this means [39, 81] though rare involve-
ment of the glomerulus still suggests this possibility [40]. We
wereunable todemonstrate glomerularor tubularpathology
in the 2 pigs that we have examined (unpublished data).
Thus, respiratory tract secretions may be the main mode
of pig-to-human NiV transmission. On the other hand, ex-
tensive kidney involvement in dogs and cats, implicated as
minor intermediate hosts, may be via contaminated urine
and in cats via respiratory secretions as well [25, 67, 71, 86].
Ifoneconsidersasaprerequisiteforagoodanimalmodel
encephalitis and neuronal involvement in the CNS, in addi-
tion to systemic vasculopathy and severe inﬂammation in
the lung, kidney, and other major organs, then perhaps the
hamster, ferret, and monkey represent the best available
small animal models of henipavirus infection. Although it is
diﬃculttodirectlycomparetherelativesusceptibilityofthese
animals to henipaviruses as the viral sources and doses, inoc-
ulationroutes,andanimalandenvironmentalcharacteristics
may be diﬀerent, perhaps among the nonhuman primates,
the African green monkey could be more susceptible than
the squirrel monkey. Nonetheless, all these models could
be useful models for pathogenesis, therapeutic and vaccine
studies as have already been done [77, 79, 87]. Overall, all the
animal models conﬁrm the dual pathogenetic mechanisms
postulated for tissue injury in henipavirus infection, namely,
vasculopathy-associated microinfarction and direct viral
infection of extravascular parenchymal cells [61].
It is perhaps not surprising that henipaviruses cause sim-
ilarinfectiousdiseasepathologyinbothhumansandanimals
asithasnowbeenshownthattheysharethesamevirusentry
receptor. The main receptor has been identiﬁed as ephrin
B2 [88, 89], and the alternative receptor is ephrin B3 [90].
T h e s er e c e p t o r sa r eu b i q u i t o u so np l a s m am e m b r a n e so f
many mammalian cells, particularly in the blood vessels and
CNS, thus accounting for the prominent clinic pathological
features of vasculitis and CNS involvement.
The emergence of henipaviruses over a short period of
a few years underscores the growing importance of this
group of viruses as causative agents of previously unknown
zoonoses. Because pteropid bats as natural hosts are found
in many parts of the world, future henipavirus outbreaks
should be anticipated [29, 30, 91–95].
6. Addendum
AveryrecentcomparativestudyofNiVandHeVintheham-
ster model (Rockx et al. [96]) showed that while the type of
pathological lesions was essentially similar between the two,
there were diﬀerences in respiratory tract replication sites
and the onset and severity of pathological lesions. HeV-in-
d u c e dl e s i o n sw e r ef o u n dt oa p p e a re a r l i e ra n dw e r em o r e
severe.
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